VirRx, Inc.

VirRx, Inc. (VirRx) is a biotechnology company that focuses on cancer gene therapy. The research team of the company has an extensive knowledge on human adenoviruses, including construction of human adenovirus vectors for cancer gene therapy. It is also lays emphasis on developing novel drugs to treat various kinds of human cancer. The company has developed a cancer gene therapy vector which destroys only the affected tissue unlike other therapies. Further, the company will begin Phase I trials on vectors for the treatment of human cancer. VirRx is headquartered at St. Louis, in Missouri, the US.

Street: 
1609 Adgers Wharf Drive
City: 
St. Louis
Postcode: 
63017
Federal State : 
United States
WebSite: 
www.virrx.com
Fax: 
1-314-5778435

Company Index Score

Current Index Score Historical Index Score
  • VirRx, Inc. currently scores 50 % in the index.
  • VirRx, Inc. is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • VirRx, Inc. is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets